Dose escalation for salvage radiation therapy

In the late 1990s and early 2000s, the advent of more accurate linear accelerators (LINACs) and image-guidance technology for delivering therapeutic X-rays to the prostate in the treatment of prostate cancer changed the dose that could be safely given. … READ MORE …

ADT and risk for diagnosis with dementia? “Not in the UK”, they say!

Just a few weeks ago we reported data from a study in California suggesting an association between treatment with androgen deprivation therapy (ADT) for prostate cancer and subsequent risk for diagnosis with dementia or Alzheimer’s disease. … READ MORE …

The safety of treatment with statins (whether you have prostate cancer or not)

In a commentary a couple of days ago we noted some diversity among medical opinion leaders about the safety of treatment with statins. … READ MORE …

The cost and the effectiveness of genomic testing for prostate cancer risk

As regular readers will be well aware, there are now several different tests available that can be used to assess risk for low- and very low-risk forms of prostate cancer at time of diagnosis (as opposed to clinically significant forms that need early treatment). … READ MORE …

So drinking cranberry juice can lower your PSA level, but what does that mean?

As we have noted numerous times before, there are all sorts of things that can be done to lower one’s PSA level, but knowing whether these effects are clinically meaningful is a very different issue. … READ MORE …

Of statins and the prevention and treatment of prostate cancer

The question of whether or not to take a statin to either prevent or actually help in the treatment of prostate cancer has potentially just become moot for many men in America … thanks to new guidance from the US Preventive Services Task Force (USPSTF). … READ MORE …

The value of second opinions, and who one gets them from

An interesting new paper published this morning in Cancer has shown that while lots of men have been getting second opinions from urologists on what to do about a diagnosis of prostate cancer, those second opinions don’t seem to have had much impact on their care. … READ MORE …